Related Experiment Videos
Reliability and validity of health status measurement by the TAPQOL
E M Bunge1, M-L Essink-Bot, M P H M Kobussen
1Department of Public Health, Erasmus MC, University Medical Center Rotterdam, PO Box 1738, 3000 DR Rotterdam, Netherlands. e.bunge@erasmusmc.nl
Insights
The TNO-AZL Preschool children Quality of Life (TAPQOL) questionnaire is a reliable tool for measuring health related quality of life (HRQoL) in young children. It demonstrates good feasibility and validity for both infants and toddlers.
Area of Science:
- Pediatric Health Outcomes
- Quality of Life Measurement
- Child Development Research
Background:
- Health-related quality of life (HRQoL) is a crucial outcome in pediatric intervention evaluation.
- The TNO-AZL Preschool children Quality of Life (TAPQOL) instrument assesses HRQoL in preschool-aged children.
- TAPQOL is a generic measure with 12 scales covering physical, social, cognitive, and emotional functioning.
Purpose of the Study:
- Evaluate the feasibility, score distribution, internal consistency, test-retest reliability, and validity of TAPQOL scales.
- Assess TAPQOL performance in preschool children aged 2-48 months.
- Specifically evaluate feasibility, reliability, and validity for infants (2-12 months) and toddlers (12-48 months).
Main Methods:
- A mailed questionnaire was administered to a random general population sample of 500 preschool children.
- A subgroup of 159 parents completed a retest questionnaire after two weeks.
- Data analysis focused on response rates, missing answers, scale effects, reliability (Cronbach's alpha, intra-class correlations), and validity.
Main Results:
- High response rates (83% test, 75% retest) and few missing answers indicated good feasibility.
- Nine scales demonstrated good internal consistency (Cronbach's alpha >0.70).
- Test-retest reliability was generally adequate, with significant differences found between children with and without chronic conditions, supporting discriminative validity.
Conclusions:
- The TAPQOL is a feasible instrument for measuring HRQoL in preschool children.
- The majority of TAPQOL scales demonstrate acceptable reliability and discriminative validity for both infants and toddlers.
- TAPQOL supports the evaluation of pediatric interventions by providing valuable HRQoL data.
Background:
In addition to clinical measures in the evaluation of paediatric interventions, health related quality of life (HRQoL) is an important outcome. The TAPQOL (TNO-AZL Preschool children Quality of Life) was developed to measure HRQoL in preschool children. It is a generic instrument consisting of 12 scales that cover the domains physical, social, cognitive, and emotional functioning.
Aims:
To evaluate the feasibility, score distribution, internal consistency, test-retest reliability, and discriminative and concurrent validity of the TAPQOL multi-item scales in preschool children, aged 2-48 months. Also to evaluate the feasibility, reliability, and validity separately for infants (2-12 months old) and toddlers (12-48 months old).
Methods:
Parents of a random general population sample of 500 preschool children were sent a questionnaire by mail. A random subgroup of 159 parents who participated received a retest after two weeks.
Results:
The response rate was 83% at the test and 75% at the retest. There were few missing answers. Six scales showed ceiling effects. Nine scales had Cronbach's alphas >0.70. In general, score distributions and Cronbach's alphas were comparable for infants and toddlers. Test-retest showed no significant differences in mean scale scores; two scales had intra-class correlations <0.50. Five scales showed significant differences between children with no conditions versus children with two or more parent reported chronic conditions.
Conclusion:
Results showed that the TAPQOL is a feasible instrument to measure HRQoL and support the reliability and discriminative validity of the majority of its scales for infants as well as toddlers.
Related Concept Videos
Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring: Affecting Factors